LB Pharmaceuticals announced promising Phase II results for LB-102 in schizophrenia, demonstrating symptom improvement.

Kindeva and Emervax partner to develop painless vaccine delivery technology, targeting viruses like Yellow Fever, Ebola, and ...

In part two of the step-by-step scientific workflow for drug discovery series, Dr Raminderpal Singh and Nina Truter describe the functions of the workflow previously outlined and include key ...

Researchers at Huntsman Cancer Institute discover a gene variant that could predict treatment outcomes for blood cancers.

Researchers discover a genetic mechanism that influences behaviour, offering insights for RNA-based therapies.

MIT’s new open-source AI model, Boltz-1, could transform drug discovery by accurately predicting protein structures, offering global access to researchers. MIT researchers have introduced Boltz-1, an ...

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as "Necessary" are stored on your browser as they ...